Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study GlobeNewswire - Tue Feb 24, 8:15AM CST

Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files provisional...

EDSA : 6.62 (-4.06%)
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results GlobeNewswire - Fri Feb 13, 3:20PM CST

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 6.62 (-4.06%)
Edesa Biotech Reports Fiscal Year 2025 Results GlobeNewswire - Fri Dec 12, 2025

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 6.62 (-4.06%)
Interest Rate Decisions Due on Both Sides of Border Next Week Baystreet - Mon Dec 8, 2025

Monday U.S. Featured Earnings Oracle Corp. (NYSE:ORCL) (Q2) EPS for $1.29, compared ...

YEXT : 5.47 (-0.18%)
AVGO : 341.57 (-0.29%)
JOUT : 44.32 (-0.92%)
ORCL : 163.12 (+9.18%)
EDSA : 6.62 (-4.06%)
TOL : 143.24 (-1.65%)
CIEN : 339.95 (+0.77%)
COST : 992.23 (-0.51%)
FERG : 231.63 (+1.63%)
AZO : 3,712.42 (-0.37%)
ADBE : 273.70 (-0.52%)
SNPS : 432.98 (+0.08%)
Interest Rate Decisions Due on Both Sides of Border Next Week Baystreet - Mon Dec 8, 2025

Monday U.S. Featured Earnings Oracle Corp. (NYSE:ORCL) (Q2) EPS for $1.29, compared ...

YEXT : 5.47 (-0.18%)
AVGO : 341.57 (-0.29%)
JOUT : 44.32 (-0.92%)
ORCL : 163.12 (+9.18%)
EDSA : 6.62 (-4.06%)
TOL : 143.24 (-1.65%)
CIEN : 339.95 (+0.77%)
COST : 992.23 (-0.51%)
FERG : 231.63 (+1.63%)
AZO : 3,712.42 (-0.37%)
ADBE : 273.70 (-0.52%)
SNPS : 432.98 (+0.08%)
Edesa Biotech Announces Upcoming Conference Schedule GlobeNewswire - Fri Oct 31, 2025

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 6.62 (-4.06%)
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study GlobeNewswire - Tue Oct 28, 2025

Study met primary and secondary endpoints Paridiprubart demonstrated a relative reduction in the risk of death of 25% Treatment provided patients with clinically meaningful improvement in survival...

EDSA : 6.62 (-4.06%)
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results GlobeNewswire - Fri Aug 8, 2025

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases,...

EDSA : 6.62 (-4.06%)
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results GlobeNewswire - Wed May 14, 2025

EDSA : 6.62 (-4.06%)
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference GlobeNewswire - Mon Apr 28, 2025

EDSA : 6.62 (-4.06%)

Barchart Exclusives

This Dividend Stock Yielding Almost 3% Is Outperforming In 2026: Should You Buy? Barchart - Wed Mar 11, 6:30PM CDT
American Electric Power Company stock is up around 14% for the year and has a healthy dividend yield of just under 3%. Is the stock a buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot